RRML - The role of cytokines, cytogenetic factors and oncogenes in the prognosis of multiple myeloma
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- June 2024 -
 
The evaluation of a diagnostic... 10
A comprehensive review of Prof... 9
Assessment of ocrelizumab impa... 7
Romanian Review of Laboratory ... 6
Monitoring the sensitivity of ... 6
Challenges in prophylactic the... 6
Diagnostic value of stress myo... 6
Effect of Systemic Inflammator... 5
Evaluation of routine laborato... 4
The role of nitro oxidative fa... 4

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 15(2)/2009
XML
TXT

The role of cytokines, cytogenetic factors and oncogenes in the prognosis of multiple myeloma

Gabriel Dragoş I. Găman, Amelia Maria V. Găman


Abstract:

A series of cytokines, like IL-3, IL-5, IL-6, IL-10, M oncostatin, ILGF1, stimulate the growth of myelomatous cells. Some of them can worsen the prognosis of patients with multiple myeloma through their negative effects (osteolysis, inhibition of erythropoiesis) or may induce benefic effects (megakariopoiesis stimulation). The presence of chromosomal abnormalities might add to a positive prognosis (hyperdiploidia of 3, 5, 7, 9, 11, 15, 19, 21) or, conversely, could be a bad prognostic factor: t(4;14), t(14;16), del 13q and 17p13. The study of gene expression in multiple myeloma represents a modern method of identifying the genes which, through their overexpression, aggravate the patients prognosis. Until now, approximately 33000 types of these genes have been studied in multiple myeloma.

Keywords: multiple myeloma,cytokines,chromosomial abnormalities,oncogenes,prognosis.

 
  PDF Download full text PDF
(66 KB)
     
 
How to cite
Găman GDI, Găman AMV. The role of cytokines, cytogenetic factors and oncogenes in the prognosis of multiple myeloma. Rev Romana Med Lab. 2009;15(2):27-32